Our results show significant differences in biomarkers’ levels between AS patients and controls as well as significant correlations between ATX, GDF-15, TM levels, and parameters of AS severity, providing insights into the underlying pathophysiological mechanisms and their potential clinical implications. This evidence concerns the gene GDF15 and aortic valve stenosis.